康希諾生物(06185.HK)料2025年將達到收支平衡

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

康希諾生物(06185.HK)料2025年將達到收支平衡

阿思達克 12-05 11:19

內媒報道，康希諾生物(06185.HK)行政總裁宇學峰表示，預計公司到2025年將達到收支平衡，其13價肺炎疫苗將於明年底或2025年初獲批，而公司與阿斯特捷利康的mRNA疫苗合作亦順利。康希諾生物今日(5日)高開後回落，現報24.2元，跌2.81%，成交87.14萬股，涉資2,141.62萬元。

康希諾生物(06185.HK)

Relevant Stocks

康希諾生物(06185.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

康希諾生物(06185.HK)料2025年將達到收支平衡

Services

About Us

Agreement Statement